Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2025PLoS ONEOpen Access

The role of SLC2A1 in lung adenocarcinoma: From tumorigenesis to patient survival

View Full Paper
Ask AI
Bookmark
Share

Authors

ZXZijun XiaoQLQinqin LongJLJiali Liao

Discussion

Loading...

Member takes

Overview

Systematic assessment shows SLC2A1 influences tumor growth and immune response in lung adenocarcinoma, suggesting its use as a biomarker.

Key Points

  • SLC2A1 expression negatively correlates with DNA methylation in lung adenocarcinoma, highlighting its role in tumorigenesis.
  • ROC analysis indicates SLC2A1 serves as a reliable prognostic biomarker for lung adenocarcinoma outcomes.
  • In vitro and in vivo studies reveal that SLC2A1 inhibition reduces proliferation, migration, and invasion in lung adenocarcinoma cells.
  • The findings underline the importance of SLC2A1 in immune regulation and its potential therapeutic implications in lung adenocarcinoma.

Cite This Study

Xiao et al. (2025) studied this question.

synapsesocial.com/papers/68c236dfb210217d64776567https://doi.org/10.1371/journal.pone.0324043
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SMC2 as a potential prognostic biomarker in lung adenocarcinoma and its correlation with immune microenvironment2025
  2. 2SLIT2 inhibits lung adenocarcinoma progression by suppressing epithelial-mesenchymal transition2025
  3. 3APOA1 as a Potential Therapeutic Target and Novel Biomarker in Lung Adenocarcinoma2025
  4. 4SLC25A39 overexpression exacerbates lung adenocarcinoma progression and is negatively regulated by AFG3L22025 · 1 citations
  5. 5Panoramic analysis of the biological function and clinical value of SLC38A2 in human cancers: a study based on pan-cancer and single-cell analysis2025